In 2017, French researchers from the Institut National de la Recherche Agronomique (INRAE) were among the first to examine the effects of E171 nanoparticles on the body. They fed rats a dose of 10mg of E171 per kilogram of body weight per day, which was similar to human exposure in food. The research, which was published in Scientific Reports, showed that E171 was able to traverse the intestinal barrier, pass into the bloodstream, and reach other areas of the body in rats. Researchers also found a link between immune system disorders and the absorption of titanium dioxide nanoparticles. 

Of the two methods of extraction, the sulphate process is currently the most popular method of producing TiO₂ in the European Union, accounting for 70 percent of European sources. The remaining 30 percent is the result of the chloride process. On a global level, it is estimated about 40-45 percent of the world’s production is based on the chloride process.